Segment Reporting (Tables)

9 Months Ended

May 31, 2016

Segment Reporting [Abstract]

Reconciliation of Revenue from Segments to Consolidated

The following table reflects results of operations of the Company’s reportable segments (in millions):

	Retail Pharmacy
	USA		International		Pharmaceutical Wholesale		Eliminations and Unallocated  Items			Consolidated
Three Months Ended May 31, 2016
Sales to external customers	$	21,185	$	3,132	$	5,181	$	-		$	29,498
Intersegment sales		-		62		567		(629	)		-
Total Sales	$	21,185	$	3,194	$	5,748	$	(629	)	$	29,498
Adjusted Operating Income	$	1,382	$	258	$	179	$	(5	)	$	1,814

Three Months Ended May 31, 2015
Sales to external customers	$	20,425	$	3,231	$	5,139	$	-		$	28,795
Intersegment sales		-		37		569		(606	)		-
Total Sales	$	20,425	$	3,268	$	5,708	$	(606	)	$	28,795
Adjusted Operating Income	$	1,328	$	249	$	171	$	1		$	1,749

	Retail Pharmacy
	USA		International		Pharmaceutical  Wholesale		Eliminations  and Unallocated Items			Consolidated
Nine Months Ended May 31, 2016
Sales to external customers	$	63,055	$	10,218	$	15,442	$	-		$	88,715
Intersegment sales		-		196		1,729		(1,925	)		-
Total Sales	$	63,055	$	10,414	$	17,171	$	(1,925	)	$	88,715
Adjusted Operating Income	$	4,257	$	908	$	500	$	(12	)	$	5,653

Nine Months Ended May 31, 2015
Sales to external customers	$	61,027	$	5,248	$	8,647	$	-		$	74,922
Intersegment sales		-		67		926		(993	)		-
Total Sales	$	61,027	$	5,315	$	9,573	$	(993	)	$	74,922
Adjusted Operating Income	$	4,044	$	374	$	292	$	(3	)	$	4,707

Reconciliation of Operating Profit (Loss) from Segments to Consolidated

The following table reconciles adjusted operating income to operating income (in millions):

	Retail Pharmacy
	USA		International		Pharmaceutical Wholesale		Eliminations  and Unallocated Items			Consolidated
Three Months Ended May 31, 2016
Operating Income										$	1,533
Acquisition-related amortization											100
LIFO provision											93
Cost transformation											73
Acquisition-related costs											15
Adjusted Operating Income	$	1,382	$	258	$	179	$	(5	)	$	1,814

Three Months Ended May 31, 2015
Operating Income									$	1,401
Acquisition-related amortization										96
LIFO provision										69
Cost transformation										160
Acquisition-related costs										4
Store closures and other optimization costs										7
Loss on sale of business										12
Adjusted Operating Income	$	1,328	$	249	$	171	$	1	$	1,749

	Retail Pharmacy
	USA		International		Pharmaceutical  Wholesale		Eliminations  and Unallocated  Items			Consolidated
Nine Months Ended May 31, 2016
Operating Income										$	4,861
Acquisition-related amortization											282
LIFO provision											207
Cost transformation											191
Acquisition-related costs											82
Asset impairment											30
Adjusted Operating Income	$	4,257	$	908	$	500	$	(12	)	$	5,653

Nine Months Ended May 31, 2015
Operating Income										$	3,832
Increase in fair market value of AmerisourceBergen warrants											(123	)
Acquisition-related amortization											402
LIFO provision											176
Cost transformation											160
Acquisition-related costs											87
Asset impairment											110
Store closures and other optimization costs											51
Loss on sale of business											12
Adjusted Operating Income	$	4,044	$	374	$	292	$	(3	)	$	4,707